<DOC>
	<DOCNO>NCT02281630</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety KWA-0711 , determine optimal dose Chronic Constipation ( CC ) patient .</brief_summary>
	<brief_title>Phase II Dose-Finding Study KWA-0711 Patients With Chronic Constipation ( CC )</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>The patient experience few three SBMs per week 6 month prior enrollment . The patient experience one follow sign symptom 25 % bowel movement 6 month : straining , lumpy hard stool , sensation incomplete evacuation . Patients secondary constipation cause systemic disorder . Patients organic constipation . Patients receive intestinal resection .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Chronic Constipation</keyword>
	<keyword>CC</keyword>
</DOC>